首页 > 最新文献

The National medical journal of India最新文献

英文 中文
Uraemic frost: Sweating urea out. 尿毒症之霜排出尿素
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_324_2023
Arun Karat, Usha Samuel, Biju Gopinath
{"title":"Uraemic frost: Sweating urea out.","authors":"Arun Karat, Usha Samuel, Biju Gopinath","doi":"10.25259/NMJI_324_2023","DOIUrl":"10.25259/NMJI_324_2023","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"232"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macklin effect: Spontaneous pneumomediastinum caused by marijuana. 麦克林效应由大麻引起的自发性气胸。
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_95_2023
Bárbara Segura-Méndez, Álvaro Fuentes-Martín, José Soro-García
{"title":"Macklin effect: Spontaneous pneumomediastinum caused by marijuana.","authors":"Bárbara Segura-Méndez, Álvaro Fuentes-Martín, José Soro-García","doi":"10.25259/NMJI_95_2023","DOIUrl":"10.25259/NMJI_95_2023","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"231"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exchange transfusion as a therapeutic modality for aniline dye-induced methaemoglobinaemia. 交换性输血是治疗苯胺染料引起的高铁血红蛋白血症的一种方法。
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_406_21
Nidhi Gupta, Sonali Dhagia, Arjun Kelaiya, Ruksar Sama, Kiran Padhy

Methaemoglobinaemia and a Heinz-body haemolytic anaemia are uncommon but potentially treatable complications of aniline poisoning. Management of aniline poisoning is mainly removing the source of aniline exposure and management of methaemoglobinaemia. Management of methaemoglobinaemia is guided by blood methaemoglobin levels and patient symptoms. Blood methaemoglobin level <30% requires only supplemental oxygen while for methaemoglobin level >30%, intravenous methylene blue is the mainstay of treatment. All patients treated with methylene blue should be observed for delayed haemolysis, acute renal failure and cardiac complications. In patients with contraindication to methylene blue, exchange transfusion can be used while haemodialysis is reserved for complicated cases. We successfully managed 6 patients of methaemoglobinaemia due to aniline poisoning by methylene blue. Two of these patients who developed Heinz-body haemolytic anaemia with acute renal failure as a complication also required exchange transfusion.

高铁血红蛋白血症和海因茨体溶血性贫血是苯胺中毒的并发症,并不常见,但有可能治愈。苯胺中毒的治疗主要是清除苯胺接触源和治疗高铁血红蛋白血症。对高铁血红蛋白血症的处理以血液高铁血红蛋白水平和患者症状为指导。如果血液中的甲氧血红蛋白水平达到 30%,则主要采用亚甲蓝静脉注射疗法。所有接受亚甲蓝治疗的患者都应观察是否出现延迟溶血、急性肾功能衰竭和心脏并发症。对于亚甲蓝禁忌症患者,可使用交换性输血,而血液透析则用于复杂病例。我们成功处理了 6 名因亚甲蓝导致苯胺中毒而出现高铁血红蛋白血症的患者。其中两名患者并发了海因茨体溶血性贫血和急性肾衰竭,也需要进行换血。
{"title":"Exchange transfusion as a therapeutic modality for aniline dye-induced methaemoglobinaemia.","authors":"Nidhi Gupta, Sonali Dhagia, Arjun Kelaiya, Ruksar Sama, Kiran Padhy","doi":"10.25259/NMJI_406_21","DOIUrl":"10.25259/NMJI_406_21","url":null,"abstract":"<p><p>Methaemoglobinaemia and a Heinz-body haemolytic anaemia are uncommon but potentially treatable complications of aniline poisoning. Management of aniline poisoning is mainly removing the source of aniline exposure and management of methaemoglobinaemia. Management of methaemoglobinaemia is guided by blood methaemoglobin levels and patient symptoms. Blood methaemoglobin level <30% requires only supplemental oxygen while for methaemoglobin level >30%, intravenous methylene blue is the mainstay of treatment. All patients treated with methylene blue should be observed for delayed haemolysis, acute renal failure and cardiac complications. In patients with contraindication to methylene blue, exchange transfusion can be used while haemodialysis is reserved for complicated cases. We successfully managed 6 patients of methaemoglobinaemia due to aniline poisoning by methylene blue. Two of these patients who developed Heinz-body haemolytic anaemia with acute renal failure as a complication also required exchange transfusion.</p>","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"195-199"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detached Schwalbe line in Axenfeld-Rieger syndrome. Axenfeld-Rieger 综合征中的 Schwalbe 线脱落。
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_382_2023
Manju Pillai, Chinmayee Pabolu, Sameer Chaudhary
{"title":"Detached Schwalbe line in Axenfeld-Rieger syndrome.","authors":"Manju Pillai, Chinmayee Pabolu, Sameer Chaudhary","doi":"10.25259/NMJI_382_2023","DOIUrl":"10.25259/NMJI_382_2023","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"230"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a novel method for teaching drawing of histology diagrams to first year MBBS students. 评估向医学学士一年级学生教授绘制组织学图表的新方法。
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_852_2022
Srividya Sreenivasan, Manisha Sandeep Nakhate

Background The challenge faced by an undergraduate medical student to draw factually correct histology diagrams needs to be addressed by the use of innovative teaching strategies. We introduced a new method to teach drawing of histology diagrams and compared its outcome with two preexisting methods. We obtained feedback from the students and faculty. Methods We introduced an innovation (method 3): A validated hand-drawn pencil sketch of a histology diagram was provided to the students. Students drew on the pencil sketch with haematoxylin and eosin (H&E) pencils and coloured it. They then drew the same diagram afresh. Three diagrams of systemic histology were chosen and the evaluation criteria shared with students. The students drew all three diagrams once, each by a different method. The scores of method 3 were compared with the other two methods, copying from standard atlas (method 1) and from hand-drawn colour chart made by teacher (method 2). Feedback was sought from students and faculty by means of a google form. Results A total of 112 students (of 167 who volunteered) completed the study. The mean (SD) score obtained by method 3 (4.83 [0.298]) was higher than the mean score by method 1 (3.91 [0.95]) and method 2 (4.82 [0.27]). There was a statistically significant difference between method 3 and method 1 (p<0.01), and method 2 and method 1 (p<0.01). However, the difference in scores between methods 3 and 2 was not statistically significant (p>0.05). Conclusion We found method 3 (the innovation) to be better than one of the pre-existing methods (method 1) but not better than method 2. The quality of diagrams produced by methods 2 and 3 were better than those by method 1, and equally so. The ease of drawing and time taken to draw were the best for method 2. Hence, overall, method 2 may be adjudged the best method.

背景 医学院本科生在绘制符合事实的组织学图表方面面临挑战,需要采用创新的教学策略加以解决。我们引入了一种教授绘制组织学示意图的新方法,并将其结果与之前已有的两种方法进行了比较。我们获得了学生和教师的反馈意见。方法 我们引入了一种创新方法(方法 3):向学生提供经过验证的组织学图手绘铅笔草图。学生们用血红素和伊红(H&E)铅笔在铅笔草图上作画并上色。然后,他们重新绘制相同的图表。我们选择了三幅系统组织学图,并与学生分享了评价标准。学生们用不同的方法将三幅图都画了一遍。将方法 3 的得分与其他两种方法进行了比较,即根据标准图集临摹(方法 1)和根据教师手绘的彩色图表临摹(方法 2)。通过谷歌表格征求学生和教师的反馈意见。结果 共有 112 名学生(167 人自愿参加)完成了研究。方法 3 的平均得分(标清)(4.83 [0.298])高于方法 1(3.91 [0.95])和方法 2(4.82 [0.27])。方法 3 与方法 1 之间的差异具有统计学意义(P0.05)。结论 我们发现方法 3(创新)优于先前存在的一种方法(方法 1),但不优于方法 2。方法 2 和方法 3 所绘制图表的质量优于方法 1,且不相上下。方法 2 的易绘制性和绘制时间最好。因此,总体而言,方法 2 可被评为最佳方法。
{"title":"Evaluation of a novel method for teaching drawing of histology diagrams to first year MBBS students.","authors":"Srividya Sreenivasan, Manisha Sandeep Nakhate","doi":"10.25259/NMJI_852_2022","DOIUrl":"10.25259/NMJI_852_2022","url":null,"abstract":"<p><p>Background The challenge faced by an undergraduate medical student to draw factually correct histology diagrams needs to be addressed by the use of innovative teaching strategies. We introduced a new method to teach drawing of histology diagrams and compared its outcome with two preexisting methods. We obtained feedback from the students and faculty. Methods We introduced an innovation (method 3): A validated hand-drawn pencil sketch of a histology diagram was provided to the students. Students drew on the pencil sketch with haematoxylin and eosin (H&E) pencils and coloured it. They then drew the same diagram afresh. Three diagrams of systemic histology were chosen and the evaluation criteria shared with students. The students drew all three diagrams once, each by a different method. The scores of method 3 were compared with the other two methods, copying from standard atlas (method 1) and from hand-drawn colour chart made by teacher (method 2). Feedback was sought from students and faculty by means of a google form. Results A total of 112 students (of 167 who volunteered) completed the study. The mean (SD) score obtained by method 3 (4.83 [0.298]) was higher than the mean score by method 1 (3.91 [0.95]) and method 2 (4.82 [0.27]). There was a statistically significant difference between method 3 and method 1 (p<0.01), and method 2 and method 1 (p<0.01). However, the difference in scores between methods 3 and 2 was not statistically significant (p>0.05). Conclusion We found method 3 (the innovation) to be better than one of the pre-existing methods (method 1) but not better than method 2. The quality of diagrams produced by methods 2 and 3 were better than those by method 1, and equally so. The ease of drawing and time taken to draw were the best for method 2. Hence, overall, method 2 may be adjudged the best method.</p>","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"209-214"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence-powered Healthcare for India: Promises, opportunities and challenges. 印度的人工智能医疗保健:前景、机遇和挑战。
Pub Date : 2024-07-01 DOI: 10.25259/NMJI_1193_2024
Ashish Makani, Anurag Agrawal, Anjali Agrawal
{"title":"Artificial Intelligence-powered Healthcare for India: Promises, opportunities and challenges.","authors":"Ashish Makani, Anurag Agrawal, Anjali Agrawal","doi":"10.25259/NMJI_1193_2024","DOIUrl":"10.25259/NMJI_1193_2024","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 4","pages":"177-180"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autologous stem cell transplantation can potentially reverse dialysis dependence in patients with myeloma: Report of two cases and practical considerations. 自体干细胞移植有可能逆转骨髓瘤患者对透析的依赖:两个病例的报告和实际考虑因素。
Pub Date : 2024-05-01 DOI: 10.25259/NMJI_268_2023
Suvir Singh, Rintu Sharma, Jagdeep Singh, Kunal Jain, Rajesh Kumar, Vikram Narang

Background Autologous stem cell transplantation (ASCT) is potentially beneficial for patients with myeloma-related renal impairment but is associated with high rates of complications in dialysis-dependent patients and requires specific precautions. Methods Patients diagnosed with myeloma and concomitant dialysis-dependent renal dysfunction were admitted for ASCT after achieving at least partial response with bortezomib-based induction therapy. For both patients, mobilization consisted of granulocyte colony stimulating factor for 5 days and CD34 directed Plerixafor on Day 1. Melphalan was administered at a dose of 140 mg/m2 and a pre-emptive session of haemodialysis was planned 24 hours after melphalan. Peripheral blood stem cell infusion was done after 24 hours. A central venous sample for blood gas analysis was obtained daily and ad hoc dialysis was planned at the earliest sign of metabolic acidosis (pH <7.35, HCO3 <15 or K >6 mEq/L). Results Two patients with biopsy proven cast nephropathy and dialysis dependence (twice a week) were taken for ASCT with the above protocol. No variation from usual stem cell yield or engraftment kinetics was noted. Patient 1 (M, 49 years) achieved very good partial response post-transplant and has been dialysis free for 18 months post-ASCT. Patient 2 (M, 48 years) achieved negative immunofixation post-ASCT and was dialysis free for 9 months post-transplant, following which he requires one session of dialysis every 3-4 weeks for onset of uraemic symptoms. Conclusions ASCT in dialysis-dependent patients is associated with a higher risk of drug toxicity, infections and transplant-related mortality. Use of reduced dose melphalan, pre-emptive dialysis after 24 hours and monitoring for acidosis and symptoms of uraemia to identify acidosis at an early stage allows safe administration of high dose chemotherapy. A major proportion of patients can potentially achieve reduction or freedom from dialysis support post-transplant.

背景 自体干细胞移植(ASCT)可能对骨髓瘤相关肾功能损害患者有益,但在依赖透析的患者中并发症发生率较高,需要采取特殊的预防措施。方法 被诊断患有骨髓瘤并同时伴有透析依赖性肾功能障碍的患者在接受硼替佐米诱导疗法至少获得部分应答后入院接受 ASCT。对于这两名患者,动员治疗包括使用粒细胞集落刺激因子 5 天,以及在第 1 天使用 CD34 引导的 Plerixafor。美法仑的剂量为140毫克/平方米,并计划在美法仑24小时后先行进行一次血液透析。24 小时后进行外周血干细胞输注。每天采集中心静脉样本进行血气分析,一旦出现代谢性酸中毒(pH 值为 6 mEq/L),即计划进行临时透析。结果 两名活检证实患有铸型肾病并依赖透析(每周两次)的患者按照上述方案进行了体外干细胞移植。与通常的干细胞产量或移植动力学相比,没有发现任何差异。患者1(男,49岁)在移植后获得了非常好的部分反应,并且在接受造血干细胞移植后的18个月内一直没有透析。患者 2(男,48 岁)在 ASCT 后免疫固定检测结果为阴性,移植后 9 个月无透析,此后因出现尿毒症症状,需要每 3-4 周透析一次。结论 依赖透析的患者进行 ASCT 与较高的药物毒性、感染和移植相关死亡率风险相关。使用小剂量美法仑、24 小时后进行先发制人的透析、监测酸中毒和尿毒症症状以尽早发现酸中毒,可以安全地进行大剂量化疗。大部分患者有可能在移植后减少或摆脱透析支持。
{"title":"Autologous stem cell transplantation can potentially reverse dialysis dependence in patients with myeloma: Report of two cases and practical considerations.","authors":"Suvir Singh, Rintu Sharma, Jagdeep Singh, Kunal Jain, Rajesh Kumar, Vikram Narang","doi":"10.25259/NMJI_268_2023","DOIUrl":"https://doi.org/10.25259/NMJI_268_2023","url":null,"abstract":"<p><p>Background Autologous stem cell transplantation (ASCT) is potentially beneficial for patients with myeloma-related renal impairment but is associated with high rates of complications in dialysis-dependent patients and requires specific precautions. Methods Patients diagnosed with myeloma and concomitant dialysis-dependent renal dysfunction were admitted for ASCT after achieving at least partial response with bortezomib-based induction therapy. For both patients, mobilization consisted of granulocyte colony stimulating factor for 5 days and CD34 directed Plerixafor on Day 1. Melphalan was administered at a dose of 140 mg/m2 and a pre-emptive session of haemodialysis was planned 24 hours after melphalan. Peripheral blood stem cell infusion was done after 24 hours. A central venous sample for blood gas analysis was obtained daily and ad hoc dialysis was planned at the earliest sign of metabolic acidosis (pH <7.35, HCO3 <15 or K >6 mEq/L). Results Two patients with biopsy proven cast nephropathy and dialysis dependence (twice a week) were taken for ASCT with the above protocol. No variation from usual stem cell yield or engraftment kinetics was noted. Patient 1 (M, 49 years) achieved very good partial response post-transplant and has been dialysis free for 18 months post-ASCT. Patient 2 (M, 48 years) achieved negative immunofixation post-ASCT and was dialysis free for 9 months post-transplant, following which he requires one session of dialysis every 3-4 weeks for onset of uraemic symptoms. Conclusions ASCT in dialysis-dependent patients is associated with a higher risk of drug toxicity, infections and transplant-related mortality. Use of reduced dose melphalan, pre-emptive dialysis after 24 hours and monitoring for acidosis and symptoms of uraemia to identify acidosis at an early stage allows safe administration of high dose chemotherapy. A major proportion of patients can potentially achieve reduction or freedom from dialysis support post-transplant.</p>","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 3","pages":"138-140"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revised point system for publications by Dental Council of India. 印度牙科理事会修订的出版物评分系统。
Pub Date : 2024-05-01 DOI: 10.25259/NMJI_1173_2023
Balaji Manohar, Richik Chakraborty
{"title":"Revised point system for publications by Dental Council of India.","authors":"Balaji Manohar, Richik Chakraborty","doi":"10.25259/NMJI_1173_2023","DOIUrl":"https://doi.org/10.25259/NMJI_1173_2023","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 3","pages":"170-171"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haemodiafiltration or haemodialysis in kidney failure. 肾衰竭的血液滤过或血液透析。
Pub Date : 2024-05-01 DOI: 10.25259/NMJI_212_2024
Gopesh K Modi, Sumit Kumar
{"title":"Haemodiafiltration or haemodialysis in kidney failure.","authors":"Gopesh K Modi, Sumit Kumar","doi":"10.25259/NMJI_212_2024","DOIUrl":"https://doi.org/10.25259/NMJI_212_2024","url":null,"abstract":"","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 3","pages":"143-144"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142485289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
V.R. Khanolkar's initial years as pathologist and researcher in India: 1924-1941. V.R. Khanolkar 在印度担任病理学家和研究员的最初几年:1924-1941.
Pub Date : 2024-05-01 DOI: 10.25259/NMJI_682_2023
Sanjay A Pai, Dhaneshwar N Lanjewar, Amita S Joshi

Vasant Ramji Khanolkar was the first Indian pathologist and a pioneering researcher who was at the forefront of the diverse fields of cancer research, blood group genetics, epidemiology and leprosy research, etc. in the mid-twentieth century. All his cutting-edge research took place after he joined Tata Memorial Hospital, Bombay (now Mumbai), as Director of Laboratories. There is little evidence of his research in the first 17 years of his career in India, at J.J. Hospital and K.E.M. Hospital, Bombay. We tried to address this gap by attempting to obtain information on Khanolkar's papers from PubMed, prior to his having joined Tata Memorial Hospital. We evaluated the abstracts of the presentations that he made at the meetings of the Teaching Pathologists Association, Bombay. Finally, we extracted from the autopsy registers at the two hospitals, any useful information about the autopsies that he had performed. Khanolkar performed preliminary laboratory research in anaemia as well as some experimental pathology in his stint at K.E.M. Hospital. Further, surprisingly, histology was not performed on most autopsies at J.J. Hospital for the period that he was Professor, but was done at K.E.M. Hospital. Why Khanolkar was a late bloomer and did not perform much research or publish in the first two institutions that he was Professor at, remains a mystery.

瓦桑特-拉姆吉-卡诺尔卡尔是印度第一位病理学家和研究先驱,在二十世纪中叶,他在癌症研究、血型遗传学、流行病学和麻风病研究等多个领域都处于领先地位。他的所有前沿研究都是在他加入孟买(现孟买)塔塔纪念医院担任实验室主任之后进行的。关于他在印度 J.J. 医院和孟买 K.E.M. 医院工作的前 17 年的研究,几乎没有任何证据。为了填补这一空白,我们试图从 PubMed 上获取 Khanolkar 加入塔塔纪念医院之前的论文信息。我们评估了他在孟买教学病理学家协会会议上的发言摘要。最后,我们从两家医院的尸检登记簿中提取了有关他所做尸检的有用信息。卡诺尔卡尔在 K.E.M. 医院任职期间进行了初步的贫血实验室研究和一些实验病理学研究。此外,令人惊讶的是,在他担任教授期间,J.J.医院并没有对大多数尸体解剖进行组织学研究,但在 K.E.M. 医院却进行了研究。Khanolkar为何大器晚成,在他担任教授的前两家医院都没有开展太多研究或发表论文,这仍然是个谜。
{"title":"V.R. Khanolkar's initial years as pathologist and researcher in India: 1924-1941.","authors":"Sanjay A Pai, Dhaneshwar N Lanjewar, Amita S Joshi","doi":"10.25259/NMJI_682_2023","DOIUrl":"10.25259/NMJI_682_2023","url":null,"abstract":"<p><p>Vasant Ramji Khanolkar was the first Indian pathologist and a pioneering researcher who was at the forefront of the diverse fields of cancer research, blood group genetics, epidemiology and leprosy research, etc. in the mid-twentieth century. All his cutting-edge research took place after he joined Tata Memorial Hospital, Bombay (now Mumbai), as Director of Laboratories. There is little evidence of his research in the first 17 years of his career in India, at J.J. Hospital and K.E.M. Hospital, Bombay. We tried to address this gap by attempting to obtain information on Khanolkar's papers from PubMed, prior to his having joined Tata Memorial Hospital. We evaluated the abstracts of the presentations that he made at the meetings of the Teaching Pathologists Association, Bombay. Finally, we extracted from the autopsy registers at the two hospitals, any useful information about the autopsies that he had performed. Khanolkar performed preliminary laboratory research in anaemia as well as some experimental pathology in his stint at K.E.M. Hospital. Further, surprisingly, histology was not performed on most autopsies at J.J. Hospital for the period that he was Professor, but was done at K.E.M. Hospital. Why Khanolkar was a late bloomer and did not perform much research or publish in the first two institutions that he was Professor at, remains a mystery.</p>","PeriodicalId":519891,"journal":{"name":"The National medical journal of India","volume":"37 3","pages":"155-161"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The National medical journal of India
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1